Cannasoul R&D

Cannasoul R&D is an Israel-based biotechnology company specializing in the scientific research and development of medical cannabis and other plant-derived compounds. Founded by Professor Dedi Meiri of the Technion, the company utilizes advanced analytical chemistry and biological assays to identify specific cannabinoid and terpene profiles for targeted therapeutic indications. Cannasoul provides a comprehensive suite of services including analytical testing, clinical trial management, and product formulation for the global cannabis industry. Their research focuses on optimizing cannabis-based treatments for complex conditions such as oncology, neurology, and inflammatory diseases through a data-driven, personalized medicine approach.